Alector (ALEC) Net Shares Issued and Repurchased (2018 - 2025)
Alector's (ALEC) quarterly Net Shares Issued and Repurchased came in at $3.2 million in Q4 2025, up 126.92% year-over-year from $1.4 million in Q4 2024, and up 126.92% quarter-over-quarter from $1.4 million in Q4 2024.
Analysis
Alector (ALEC) Net Shares Issued and Repurchased (2018 - 2025) Analysis & Trends
Alector (ALEC) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 126.92% year-over-year to $3.2 million in Q4 2025; TTM through Dec 2025 was $3.2 million, a 126.92% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 126.92% from the prior year.
- Net Shares Issued and Repurchased was $3.2 million for Q4 2025 at Alector, up from $1.4 million in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $5.0 million in Q4 2022 and troughed at $521748.0 in Q1 2021.
- A 5-year average of $2.3 million and a median of $1.8 million in 2022 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased soared 202.02% in 2022 and tumbled 58.82% in 2023, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $3.3 million in 2021, then jumped by 53.07% to $5.0 million in 2022, then plunged by 58.82% to $2.1 million in 2023, then slumped by 31.4% to $1.4 million in 2024, then soared by 126.92% to $3.2 million in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $3.2 million (Q4 2025), $1.4 million (Q4 2024), and $2.1 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Mar 31, 2023 | 985,811.00 |
| Dec 31, 2022 | 5.00 Mn |
| Mar 31, 2022 | 1.58 Mn |
| Dec 31, 2021 | 3.26 Mn |
| Mar 31, 2021 | 521,748.00 |
| Dec 31, 2020 | 5.60 Mn |
| Mar 31, 2020 | 1.04 Mn |
| Dec 31, 2019 | 3.74 Mn |
| Mar 31, 2019 | 422,600.00 |
| Dec 31, 2018 | 5.06 Mn |